Vimarsana
Biggest News Aggregation in the World

Page 20 - Sclerosis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sclerosis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sclerosis Today - Breaking & Trending Today

Enzolytics, Inc. Receives Official Filing Receipt for Multiple Sclerosis Patent Application - Vimarsana News

Enzolytics, Inc. Receives Official Filing Receipt for Multiple Sclerosis Patent Application

Enzolytics, Inc. Receives Official Filing Receipt for Multiple Sclerosis Patent Application Third Tranche of $1.2 Million Financing Completed COLLEGE STATION, TX / ACCESSWIRE / January 19, 2021 / Enzolytics, Inc. (OTC PINK:ENZC)(the "Company") today, announced it has received the official filing receipt from the U.S. Patent Office confirming the filing of its patent application for "Nuclear Proteins Isolated from Mammalian Spinal Cord Immune Factor - Pharmaceutical Composition for Treatment" and has received the third tranche of the $1.2 million dollar financing. The Company expects to file t...

Myelin‐specific T cells implicated in central nervous system disease in monkeys - Vimarsana News

Myelin‐specific T cells implicated in central nervous system disease in monkeys

Myelin‐specific T cells implicated in central nervous system disease in monkeys Scientists have uncovered new clues implicating a type of herpes virus as the cause of a central nervous system disease in monkeys that's similar to multiple sclerosis in people. The findings, published in the Annals of Clinical and Translational Neurology, expand on previous work to understand the cause of the disease and potentially develop antiviral therapies. The work was led by scientists at Oregon Health & Science University. "This gives us a better understanding of the model," said Scott Wong, Ph.D., sen...

Novel compound appears to protect myelin and nerve fibers - Vimarsana News

Novel compound appears to protect myelin and nerve fibers

Novel compound appears to protect myelin and nerve fibers A compound developed at Oregon Health & Science University appears to protect nerve fibers and the fatty sheath, called myelin, that covers nerve cells in the brain and spinal cord. The discovery, published in the Journal of Neuroimmunology, could be important in treating or preventing the progression of multiple sclerosis and other central nervous system disorders. The new research in a mouse model advances earlier work to develop the compound - known as sobetirome - that has already showed promise in stimulating the repair of myelin...

Gene therapy can effectively treat mice with tuberous sclerosis complex, shows study - Vimarsana News

Gene therapy can effectively treat mice with tuberous sclerosis complex, shows study

Gene therapy can effectively treat mice with tuberous sclerosis complex, shows study Patients with tuberous sclerosis complex, a genetic disorder characterized by the growth of noncancerous tumors in multiple organs of the body, have limited treatment options. A team led by investigators at Massachusetts General Hospital (MGH) has now shown that gene therapy can effectively treat mice that express one of the mutated genes that cause the disease. The research is published in Science Advances. The gene, called TSC2, codes for tuberin, a protein that acts to inhibit cell growth and proliferatio...

New approach can help identify novel treatments for autoimmune diseases - Vimarsana News

New approach can help identify novel treatments for autoimmune diseases

New approach can help identify novel treatments for autoimmune diseases A team of researchers led by the Indiana Biosciences Research Institute Diabetes Center's Scientific Director Decio L. Eizirik, MD, Ph.D., has found that identifying new treatments for autoimmune diseases requires studying together the immune system and target tissues. This study, "Gene expression signatures of target tissues in type 1 diabetes, lupus erythematosus, multiple sclerosis, and rheumatoid arthritis," is featured in the Jan. 6, 2021, edition of Science Advances. We must move away from the present "immune-centr...